[Parotid tumors of intermediate malignancy. Prognostic assessment. Review of the literature].
In 264 patients operated at Hôpital Boucicault for neoplasma of the parotid gland, 9 presented mucoepidermoid carcinoma and 4 had acinic cell adenocarcinoma. These latter 13 cases of intermediate malignancy tumors were assessed, although the retrospective follow-up period was insufficient to formulate an estimate on the survival rate of these patients. The authors further review the bibliographical data useful in evaluating the prognosis for such neoplasia. They stress the controversy existing around opinions concerning histology-based prognosis and recent advance on nuclear DNA. Indications for postoperative radiotherapy is discussed.
Marie
J P
JP
Service ORL et Chirurgie Cervico-faciale, Hôpital Ch.-Nicolle, Rouen, Paris.
Trotoux
J
J
Vildé
F
F
Clavier
A
A
Aubert
P
P
D002277:Carcinoma / Q000473:pathology* / Q000628:therapy; D006801:Humans; D009367:Neoplasm Staging; D010307:Parotid Neoplasms / Q000473:pathology* / Q000628:therapy; D011379:Prognosis
Tumeurs parotidiennes à malignité intermédiaire. Appréciation pronostique. Mise au point bibliographique.